Results 181 to 190 of about 12,533 (219)
Some of the next articles are maybe not open access.

Acellular Pertussis Vaccines

American Journal of Diseases of Children, 1991
The efficacy of two acellular pertussis vaccines was estimated for various clinical case definitions, with and without the requirement of culture confirmation, from a randomized trial in Sweden. Efficacy increased with duration of coughing spasms and when the case definition included whoops or whoops plus at least nine coughing spasms a day.
W C, Blackwelder   +3 more
openaire   +2 more sources

Acellular pertussis vaccines

Pediatric Infectious Disease Journal, 1987
A R, Hinman, I M, Onorato
openaire   +2 more sources

Pertussis vaccines: acellular versus whole‐cell

Medical Journal of Australia, 1996
Acellular pertussis vaccines containing purified Bordetella pertussis antigens have now been extensively field tested. They produce a significantly lower rate of reactions than whole-cell vaccines and their efficacy is either comparable or superior.
openaire   +2 more sources

Acellular Vaccines and Resurgence of Pertussis

JAMA, 2012
PERTUSSIS IS A HIGHLY CONTAGIOUS, VACCINEpreventable disease for which a whole-cell vaccine (killed bacteria), in combination with toxoids against diphtheria and tetanus (DTwP), was introduced for immunization of children in the United States in the 1940s. With the eventual widespread use of DTwP vaccine, the national annual incidence of reported cases
openaire   +2 more sources

ACELLULAR PERTUSSIS VACCINES

2016
Pertussis is a dangerous infectious disease that is well controlled world-wide by widespread immunization. The major cause of the decline in the morbidity and mortality of the disease is the intensive World Health Organization's Expanded Program on Immunization.
openaire   +1 more source

[Acellular anti-pertussis vaccine].

Bulletin de la Societe de pathologie exotique (1990), 1992
Since several years, pertussis has increased especially in non-immunized young infants under 6 months of age, in countries where pertussis-immunization is in widespread use. The whole-cellular pertussis vaccine so far used in these countries is not well tolerated, has been indicted in adverse neurological complications, and offers significant but ...
P, Bégué, E, Grimpel, S, Baron
openaire   +1 more source

Acellular pertussis vaccine

Drugs of the Future, 1988
A. Robinson, L.E. Irons, L.A.E. Ashworth
openaire   +1 more source

Designing spatial and temporal control of vaccine responses

Nature Reviews Materials, 2021
Shih Hao Ou, Wei Luo, Bali Pulendran
exaly  

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology, 2021
Aakash Desai   +2 more
exaly  

Home - About - Disclaimer - Privacy